XML 30 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments
3 Months Ended
Mar. 31, 2018
Financial Instruments [Abstract]  
Financial Instruments
13. Financial Instruments

In the normal course of business, the Company uses derivative financial instruments to manage foreign currency exchange rate risk. Currency exposure is monitored and managed by the Company as part of its risk management program which seeks to reduce the potentially adverse effects that market volatility could have on operating results. The Company's derivative financial instruments consist of non-deliverable foreign currency forward contracts. Derivative financial instruments are neither held nor issued by the Company for trading purposes.

Derivatives Not Designated as Hedging Instruments

Both the gain or loss on the derivatives not designated as hedging instruments and the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as hedges were immaterial during each of the three months ended March 31, 2018 and 2017. Gains and losses on these contracts are recorded in net other expense (income) and net interest expense in the Unaudited Condensed Consolidated Statements of Operations and are offset by losses and gains on the related hedged items.  The fair value of the Company's derivative instruments outstanding as of March 31, 2018 was immaterial.

The notional amounts of the Company's derivative instruments outstanding were as follows (in thousands):

 
 
March 31, 2018
  
December 31, 2017
 
Derivatives not designated as hedges
      
Foreign exchange contracts
 
$
3,160
  
$
3,979
 
Total derivatives not designated as hedges
 
$
3,160
  
$
3,979